ProductsBack/Anti-human Granzyme A mAb (GA28), biotin

Anti-human Granzyme A mAb (GA28), biotin

Name: Anti-human Granzyme A mAb (GA28), biotin
SKU: 3484-6_M04
Price: 1170 EUR
Availability: BackOrder

3484-6

ApplicationsELISA

Product group Antibodies

ReactivityHuman

TargetGZMA

Overview

Supplier
Mabtech
Product Name
Anti-human Granzyme A mAb (GA28), biotin
Delivery Days Customer
9
Applications
ELISA
Certification
Research Use Only
Clonality
Monoclonal
Clone ID
GA28
Conjugate
Biotin
Gene ID3001
Target name
GZMA
Target description
granzyme A
Target synonyms
CTL tryptase; CTLA3; cytotoxic T-lymphocyte proteinase 1; Cytotoxic T-lymphocyte-associated serine esterase-3; fragmentin-1; granzyme 1; granzyme A; Granzyme A (Cytotoxic T-lymphocyte-associated serine esterase-3; Hanukah factor serine protease); granzyme A (granzyme 1, cytotoxic T-lymphocyte-associated serine esterase 3); h factor; Hanukah factor serine protease); HF; HFSP
Host
Mouse
Isotype
IgG1
Reactivity
Human
UNSPSC
12352203

Tang, J., et al. (2017). CXCR5+CD8+ T cells present elevated capacity in mediating cytotoxicity toward autologous tumor cells through interleukin 10 in diffuse large B-cell lymphoma. Int Immunopharmacol.
Read more
Herth, I., et al. (2013). Thalidomide maintenance therapy maturates the T cell compartment and compromises antigen-specific antitumor immunity in patients with multiple myeloma. Exp Hematol.
Read more
Ma, Q. Y., et al. (2017). Exposure to particulate matter 2.5 (PM2.5) induced macrophage-dependent inflammation, characterized by increased Th1/Th17 cytokine secretion and cytotoxicity. Int Immunopharmacol.
Read more
Qiu, H., et al. (2017). Interleukin 10 enhanced CD8+ T cell activity and reduced CD8 + T cell apoptosis in patients with diffuse large B cell lymphoma. Experimental Cell Research.
Read more